大千有没有生物医学背景的专家看看这个报告的真伪:
“Conclusion:
We conclude that the controversy surrounding the plasma P-tau181 data is much ado about nothing. There are no indications of deliberate manipulation. We thank all the critics for prompting independent efforts from our data scientists to not only validate the data but bolster the argument that we can expect positive cognitive endpoint outcomes from upcoming Phase 3 trials.”
结论 :我们得出的结论是,围绕血浆 P-tau181 数据的争议是无关紧要的。 没有任何故意操纵的迹象。 我们感谢所有批评者促使我们的数据科学家做出独立努力,不仅验证数据,而且支持我们可以期待即将到来的第 3 阶段试验的积极认知终点结果的论点。
SavaDx Poster and Plasma Ptau-181 Data
Note: this is part 2 of the Science Integrity series
信息分享,不是投资指南!